MIRNA

MI:RNA is a pioneering diagnostics company using microRNA biomarker technology for early disease diagnosis, combined with bespoke artificial intelligence modelling for prediction and prognosis of disease outcomes. Founded in 2019 by Dr Eve Hanks, MI:RNA was the first spinout from Scotland’s Rural College and is recognised globally for its innovation in animal health and precision medicine.

This revolutionary approach to diagnostics identifies disease earlier with improved accuracy across multiple species and disease types, and provides insights into disease progression using just a simple blood, urine or milk sample. MI:RNA’s extensive pipeline of cutting-edge research focuses on chronic disease in companion animals — such as cardiac, kidney, cancer, osteoarthritis and dermatitis — as well as Johne’s disease in cattle and bovine tuberculosis.

With a multi-award-winning team of experts from across the globe, and an outstanding array of collaborations across a variety of disciplines, MI:RNA is advancing precision medicine and delivering the company’s mission: to help animals live longer, healthier lives while supporting sustainable farming and reducing the environmental impact of agriculture.